Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases
Clinical trial NCT02036086 · UNKNOWN
Trial details
- NCT number
- NCT02036086
- Sponsor
- Sunnybrook Health Sciences Centre
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2024-01-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.